Cepheid

About:

Cepheid is a diagnostics company that provides molecular systems and tests for organisms and genetic-based diseases.

Website: http://www.cepheid.com

Twitter/X: CepheidNews

Top Investors: U.S. Department of Defense, Biomedical Advanced Research and Development Authority (BARDA), Innogenetics, Wheatley Partners, U.S. Department of Health & Human Services

Description:

Cepheid is a molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.

Total Funding Amount:

$118M

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Sunnyvale, California, United States

Founded Date:

1996-01-01

Founders:

Allen Northrup, Dennis H. Giesing, Steve Young

Number of Employees:

1001-5000

Last Funding Date:

2021-10-22

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai